SMA News Today Home | SMA News Today
WEBSep 18, 2024 · The use of ultrasound to guide the administration of Spinraza (nusinersen) injection into the spinal canals of adults with spinal muscle atrophy (SMA) significantly reduced the number of needle redirections compared with a standard, landmark-based approach, according to a clinical trial. Among patients with …
HCP SMA News Today – The Web's Leading Resource For People …
WEBTreatment with Spinraza (nusinersen) generally stabilized or improved motor function for older patients with spinal muscular atrophy (SMA), according to a review and meta-analysis of previously published observational studies. The new analysis, which spanned a treatment period of up to two years, involved adults and adolescents with….
Spinal Muscular Atrophy: Nutrition and Supplementation
WEBThe nutritional management of patients with progressive neuromuscular diseases like Spinal Muscular Atrophy (SMA) is complex and is achieved optimally with an individualized approach from a multidisciplinary care team. 1,2 Patients with SMA need nutritional monitoring at least annually with assessment of caloric intake and standard ...
Spinal Muscular Atrophy: Cardiac Disease – HCP SMA News Today
WEBSpinal Muscular Atrophy (SMA) is an inherited neurodegenerative disease, 1 but it is increasingly clear that the pathology of SMA extends beyond ventral horn spinal cord neurons and includes the heart among other organs. 2 In patients with SMA, tissue levels of SMN1 protein are reduced in heart tissues, 3 and numerous mouse models of SMA exhibit cardiac developmental abnormalities which ...
SMA Type 4: Symptoms, Treatment, and More - SMA News Today
WEBFeb 2, 2023 · Type 4. Age of onset. During adulthood, usually after age 35. Symptoms. Progressive muscle weakness, usually starting in the legs. Fatigue, numbness, and cramping. Mild hand and finger tremors. Prognosis. Lifespan is unaffected, and most patients retain the ability to walk independently.
SMA Type 0: Symptoms, Treatment, and More - SMA News Today
WEBFeb 2, 2023 · What are the symptoms of SMA type 0? Spinal muscular atrophy type 0 is defined by symptoms that appear before birth, while a developing fetus is still in the womb. Usually, the first detectable symptom is a reduction in the fetus’ movement, or a complete absence of fetal movement, in the later stages of pregnancy. Because it manifests prior to birth, type 0 is sometimes referred to as ...
Across August, Variety of Events Celebrate SMA Awareness Month
WEBAug 2, 2021 · To mark Awareness Month, Bionews, which publishes SMA News Today, is again reprising its “ 31 Days of SMA ” series throughout the month. Each day in August, a different member of the SMA community — patients, caregivers, family members, and others — will share their journey and unique insight into living with SMA.
Branaplam – HCP SMA News Today
WEBBranaplam (LMI070, NVS-SM1; developed by Novartis) is a small molecule that stabilizes the transient double-strand RNA structure formed by the SMN2 pre-mRNA and U1 small nuclear ribonucleic protein complex. 8 Branaplam is currently being tested in an open-label, first-in-human, proof of concept Phase I/II clinical study in infants with SMA type ...
Coccyx Mobilization for Increased Comfort – HCP SMA News Today
WEBMar 22, 2022 · The idea was to increase the mobility of the coccyx to allow for the coccyx to be in a more comfortable position when Michael is sitting in his wheelchair. To allow for even more comfort and the ability for Michael to perform weight shifting throughout the day, we are working on getting him in his new wheelchair, which has the capability to ...
With Zolgensma, Gene Therapy Takes Step Forward in Treating …
WEBby Emma Yasinski May 31, 2019. Zolgensma ‘s approval as the first gene therapy for treating all forms of spinal muscular atrophy (SMA) in children up to 2 years old is another step forward — an exceptional and far-reaching one — in the seeming revolution underway in treating more diseases, and an increasing number of rare ones, by ...